U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. Sumit Sarkar
  1. Science & Research (NCTR)

Sumit Sarkar Ph.D.

Research Biologist — Division of Neurotoxicology

Dr. Sumit Sarkar
Sumit Sarkar, Ph.D.

(870) 543-7121
NCTRResearch@fda.hhs.gov  

Back to NCTR Principal Investigators page


 About  |  Publications  |  Lab Member


Background

Dr. Sarkar earned a doctorate in neuropharmacology and neuroscience from Nagpur University in Nagpur, India. His research contributed to the mechanistic understanding of neuropeptides—especially opiates—and their interactions with gonadotropin-releasing hormones in the hypothalamus. Dr. Sarkar received further training during a postdoctoral tenure in Dr. Ronald Lechan’s lab in the Division of Endocrinology and Metabolism at Tufts-New England Medical Center in Boston, Massachusetts, where he studied the role of neuropeptides in regulating thyrotropin-releasing hormone (TRH) and corticotropin-releasing hormone (CRH) in the rodent brain during episodes of fasting and bacterial infections. His postdoctoral research confirmed that the phosphorylation of Cyclic adenosine monophosphate (cAMP)-response element binding protein (CREB) is an essential step in activating thyroid and stress hormones in the brain. This specific work earned him the 2002 Abbott Laboratory “Thyroid Research Clinical Fellowship Award for Best Poster Presentation” at 84th Annual Meeting of the Endocrine Society. Later, at Indiana University, Dr. Sarkar studied emotional stress-induced cardiac regulation and fever to explore common hypothalamic origins and brain stem mechanisms and found a common locus which is the key in thermoregulation, locomotion, and heart rate. He worked as a clinical research fellow in the Simon Cancer Research Center in Indianapolis for one year and then joined Boston Children’s Hospital (Harvard Medical School) as a research scientist to study the role of endoplasmic reticulum stress in inducing obesity and diabetes.

Dr. Sarkar joined FDA’s National Center for Toxicological Research in 2008 and, since then, he has published 88 peer-reviewed publications. Dr. Sarkar received an FDA “Special Act Award” for exceptional productivity and special accomplishments as a research scientist and an “Outstanding Service” Group Recognition Award for exemplary work as a member of the NCTR Summer Student Research Program Committee. Dr. Sarkar is an adjunct assistant professor in the Department of Pharmacology and Toxicology and the Department of Neurobiology at University of Arkansas for Medical Sciences. In 2023, Dr. Sarkar received the “NCTR Director’s Award” for outstanding dedication to training and motivating the next generation of scientists. Dr. Sarkar serves as an expert grant reviewer on several scientific committees including the Alzheimer’s Association since 2012. Currently Dr. Sarkar reviews for publications including Current Alzheimer Research, Alzheimer’s and Dementia, Neurotoxicology, Journal of Neurochemistry, Molecular Neurobiology, Neurotoxicology and Teratology, Toxicology In Vitro, Food Chemical Toxicology, Journal of Toxicology, and Journal of Drug and Alcohol Research, as well as manuscripts for Dove Press. In 2018, Dr. Sarkar became a member of the editorial board of the journal Metabolic Brain Disease published by Springer and in 2022 he became deputy chief editor. He also serves on the editorial board of Current Alzheimer’s Research published by Bentham Publishers, Neurochemistry International published by Elsevier, and Molecular Biology Reports and BMC Neurology published by Springer Nature.

 

Research Interests

Dr. Sarkar’s research work focuses on the effects of various neurotoxicants in the brain vasculature and other components of the neurovascular unit. The components of the neurovascular units—pericytes, microglia, astrocytes, neurons, and basal lamina—act as an intricate network to maintain the neuronal homeostatic microenvironment. Disruptions to this intricate cell network due to neurotoxicant exposure can lead to neuronal malfunction and symptoms characteristic of central nervous system diseases. As the Division of Neurotoxicology’s expert on Alzheimer’s disease (AD) neuropathology, Dr. Sarkar collaborates with multiple division researchers. Currently, Dr. Sarkar’s laboratory focuses on two important areas of AD research:

  • the role of microvasculature and diet in altering neuropathology in rodent models of AD
  • comparative intestinal and neuronal pathology for biomarker identification and its correlation with microbiome in AD using Tg rats and postmortem human brain and ileal tissues

Dr. Sarkar’s expertise as a neurohistopathologist has allowed him to collaborate frequently with other principal investigators in both the Division of Neurotoxicology and other NCTR divisions.

 

Professional Societies/National and International Groups

Endocrine Society
Member
2001 – Present

Sigma Xi
Member
2009 – Present

Secretary and Treasurer
2016 – 2018 

President
2018

Society for Neuroscience – Arkansas Chapter
Member
2009 – Present

Secretary
2010 – 2013

Treasurer
2014 – 2015

Society for Neuroscience
Member
2004 – Present

 

Selected Publications

Evaluation of Styrylbenzene Analog-FSB and Its Affinity to Bind Parenchymal Plaques and Tangles of Patient of Alzheimer’s Disease.
Setti S., Das N., Raymick J., Hanig J., and Sarkar S.
Metab Brain Dis. 2022, 37(3):639-651.

Assessment of Sex-Related Cognitive Deficits in the Tg-SwDI Mouse Model of Alzheimer’s Disease.
Setti S., Flanigan T., Hanig J., and Sarkar S.
Behav Brain Res. 2022, 428:113882.

Alzheimer's Disease: A Step Closer to Understanding Type 3 Diabetes in African Americans.
Ferguson S.A., Panos J.J., Sloper D., Varma V., and Sarkar S.
Metab Brain Dis. 2021, 36(7):1803-1816.

Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H., Cuevas E., Raymick J., Robinson B., and Sarkar S.
Neuroscience. 2020, 440: 48-55.

Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H., Cuevas E., Raymick J.B., Robinson B.L., Ali S.F., Hanig J., and Sarkar S.
Curr Alzheimer Res. 2019, 16(5):388-395; PMID:30907317.

Increased Inflammation in BA21 Brain Tissue from African Americans with Alzheimer’s Disease.
Ferguson S.A., Varma V., Sloper D., Panos J.J., and Sarkar S.
Metab Brain Dis. 2020, 35(1):121-133; PMID: 31823110.

Brain Endothelial Dysfunction Following Pyrithiamine Induced Thiamine Deficiency in the Rat.
Sarkar S., Liachenko S., Paule M.G., Bowyer J., and Hanig J.P.
Neurotoxicology. 2016, 57:298-309.

Vascular-Directed Responses of Microglia Produced by Methamphetamine Exposure: Indirect Evidence That Microglia are Involved in Vascular Repair?  
Bowyer J.F., Sarkar S., Tranter K.M., Hanig J.P., Miller D.B., and O’Callaghan J.P. 
J Neuroinflammation. 2016, 13(1):64.

Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice.
Sarkar S., Raymick J., Ray B., Lahiri D.K., Paule M.G., and Schmued L. 
Curr Alz Res. 2015, 12(9): 837-46.

Histopathological and Electrophysiological Indices of Rotenone-Evoked Dopaminergic Toxicity: Neuroprotective Effects of Acetyl-L-Carnitine.
Sarkar S., Gough B., Raymick J., Beaudoin M.A., Ali S.F., Virmani A., and Binienda Z,K.
Neurosci Lett. 2015, 606: 53-9.

Chronic MPTP Treatment Produces Hyperactivity in Male Mice Which is not Alleviated by Concurrent Trehalose Treatment.
Ferguson S.A., Law C.D., and Sarkar S.
Behav Brain Res. 2015, 292: 68-78.

Neuroprotective Effect of the Chemical Chaperone, Trehalose, in a Chronic MPTP-Induced Parkinson's Disease Mouse Model.
Sarkar S., Chigurupati S., Raymick J., Mann D., Bowyer J.F., Schmitt T., Beger R.D., Hanig J.P., Schmued L.C., and Paule M.G.
Neurotoxicology. 2014, 44: 250-62.

Neurovascular Changes in Acute, Sub-Acute and Chronic Mouse Models of Parkinson's Disease.
Sarkar S., Raymick J., Mann D., Bowyer J.F., Hanig J.P., Schmued L.C., Paule M.G., and Chigurupati S.
Curr Neurovasc Res. 2014, 11(1): 48-61.

In Situ Demonstration of Fluoro-Turquoise Conjugated Gelatin for Visualizing Brain Vasculature and Endothelial Cells and Their Characterization in Normal and Kainic Acid Exposed Animals.
Sarkar S., Raymick J., Paule M.G., and Schmued L.
J Neurosci Methods. 2013, 219(2): 276-84.

Characterization of Myelin Pathology in the Hippocampal Complex of a Transgenic Mouse Model of Alzheimer’s Disease.
Schmued L.C., Raymick J., Paule M.G., Dumas M., and Sarkar S.
Curr Alzheimer Res. 2013, 10(1): 30-7.

In Vivo Administration of Fluorescent Dextrans for the Specific and Sensitive Localization of Brain Vascular Pericytes and Their Characterization in Normal and Neurotoxin Exposed Brains.
Sarkar S. and Schmued L.
Neurotoxicology. 2012, 33(3): 436-43.

Temporal Progression of Kainic Acid Induced Changes in Vascular Laminin Expression in Rat Brain with Neuronal and Glial Correlates.
Sarkar S., Raymick J., and Schmued L.
Curr Neurovasc Res. 2012, 9(2): 110-9.

Kainic Acid and 3-Nitropropionic Acid Induced Expression of Laminin in Vascular Elements of the Rat Brain.
Sarkar S. and Schmued L.
Brain Res. 2010, 1352: 239-47.

Stress- and Lipopolysaccharide-Induced C-Fos Expression and Nnos in Hypothalamic Neurons Projecting to Medullary Raphe: A Triple Immunofluorescent Labeling Study.
Sarkar S., Zaretskaia M.V., Zaretsky D.V., Moreno M., and DiMicco J.A.
Eur J Neurosci. 2007, 26(8): 2228-38.

Central Administration of Cocaine- and Amphetamine-Regulated Transcript Increases Phosphorylation of cAMP Response Element Binding Protein (CREB) in Corticotropin-Releasing Hormone-Producing Neurons but not in Prothyrotropin-Releasing Hormone-Producing Neurons in the Hypothalamic Paraventricular Nucleus.
Sarkar S., Wittman G., Fekete C., and Lechan R.M.
Brain Res. 2004, 999(2): 181-92.

Central Administration of Neuropeptide Y Reduces Alpha-Melanocyte-Stimulating Hormone-Induced Cyclic Adenosine 5’-Monophosphate Response Element Binding Protein (CREB) Phosphorylation in Pro-Thyrotropin-Releasing Hormone Neurons and Increases CREB Phosphorylation in Corticotropin-Releasing Hormones Neurons in the Hypothalamic Paraventricular Nucleus.
Sarkar S. and Lechan R.M.
Endocrinology. 2003, 144(1): 281-91.

Intracerebroventricular Administration of Alpha-Melanocyte Stimulating Hormone Increases Phosphorylation of CREB in TRH- and CRH-Producing Neurons of the Hypothalamic Paraventricular Nucleus.
Sarkar S., Légrádi G., and Lechan R.M.
Brain Res. 2002, 945(1): 50-9.

 

Lab Member

Contact information for all lab members:
(870) 543-7121
NCTRResearch@fda.hhs.gov 

James Raymick
Bio Science Laboratory Technician


Contact Information
Sumit Sarkar
(870) 543-7121
Expertise
Expertise
Approach
Domain
Technology & Discipline
Toxicology
 
Back to Top